Bioatla Inc
Biotechnology
Healthcare
BCAB
47.71 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.44
52 week high
10.78
high
2.69
52 week low
1.33
low
2.41
growth
-23.41 %
previous Close
2.46
P/E ratio
market cap
122 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-35.75 M
-37.56 %
eps
0.00 %
-29.31 %
eps surprise
-17.19 %
net profit margin
-3575200000.00 %
0.00 %
operating incoming
-37.20 M
-28.59 %
net change in cash
-23.99 M
-5.14 %
cash on hand
169 M
-12.45 %
cost of revenue
0.00 %
top top